Literature DB >> 18382112

Vitamin D: a candidate for the environmental effect in multiple sclerosis - observations from Norway.

Margitta T Kampman1, Magritt Brustad.   

Abstract

Multiple sclerosis (MS) is a chronic disease of the central nervous system, pathologically characterized by inflammation, demyelination, and axonal damage, presumably auto-immune in nature. Complex interactions between genetic susceptibility and environmental factors, such as vitamin D status and primary Epstein-Barr virus infection in adolescence or later in life, probably determine the MS risk. Norway at a latitude 58-71 degrees N is a discrete exception to the hypothesis that solar UV radiation exposure, mediated by vitamin D, coheres with the latitude gradient seen for MS prevalence. Where UV radiation exposure is low in Norway,vitamin D sufficiency is maintained through a traditional diet providing vitamin D as well as marine omega-3 polyunsaturated fatty acids. This observation supports an environmental interaction between diet and latitude, with vitamin D as the common mediator. The potential roles of vitamin D, other environmental exposures, and genes in the complex aetiology of MS are discussed in this review. (c) 2008 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18382112     DOI: 10.1159/000122330

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  28 in total

1.  Latitude has more significant impact on prevalence of multiple sclerosis than ultraviolet level or sunshine duration in Japanese population.

Authors:  Masako Kinoshita; Kaoru Obata; Masami Tanaka
Journal:  Neurol Sci       Date:  2015-03-10       Impact factor: 3.307

2.  Alaska, multiple sclerosis, and the vitamin D hypothesis.

Authors:  Trygve Holmøy; Margitta T Kampman
Journal:  J Neurol       Date:  2009-10-28       Impact factor: 4.849

3.  Association of UV radiation with multiple sclerosis prevalence and sex ratio in France.

Authors:  S-M Orton; L Wald; C Confavreux; S Vukusic; J P Krohn; S V Ramagopalan; B M Herrera; A D Sadovnick; G C Ebers
Journal:  Neurology       Date:  2011-02-01       Impact factor: 9.910

4.  The gut microbiome in multiple sclerosis.

Authors:  Daniel W Mielcarz; Lloyd H Kasper
Journal:  Curr Treat Options Neurol       Date:  2015-04       Impact factor: 3.598

5.  Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway.

Authors:  Margitta T Kampman; Jan Harald Aarseth; Nina Grytten; Espen Benjaminsen; Elisabeth Gulowsen Celius; Ole Petter Dahl; Trygve Holmøy; Kristin Løken-Amsrud; Rune Midgard; Kjell-Morten Myhr; Geir Risberg; Anita Vatne; Oivind Torkildsen
Journal:  J Neurol       Date:  2013-01-06       Impact factor: 4.849

Review 6.  Multiple sclerosis and vitamin D: a review and recommendations.

Authors:  Andrew J Solomon; Ruth H Whitham
Journal:  Curr Neurol Neurosci Rep       Date:  2010-09       Impact factor: 5.081

7.  The role of glatiramer acetate in the early treatment of multiple sclerosis.

Authors:  David W Brandes
Journal:  Neuropsychiatr Dis Treat       Date:  2010-06-24       Impact factor: 2.570

8.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

Review 9.  Association between seasonal factors and multiple sclerosis.

Authors:  Abdulla Watad; Shir Azrielant; Alessandra Soriano; Danielle Bracco; Arsalan Abu Much; Howard Amital
Journal:  Eur J Epidemiol       Date:  2016-05-25       Impact factor: 8.082

Review 10.  Clinical implications of a possible role of vitamin D in multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny
Journal:  J Neurol       Date:  2009-04-28       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.